Table 2.
NCI | MCI | AD | Shapiro–Wilk p-value* | ||
---|---|---|---|---|---|
Dataset 1 | |||||
Trk2 Expression | 1.93 ± 0.55 | 1.12 ± 0.54 | 0.92 ± 0.30 | 0.002 | |
2.06 (1.56, 2.21) | 0.87 (0.69, 1.67) | 0.76 (0.71, 1.03) | |||
Entorhinal Cortex NFT Count | 10.62 ± 9.99 | 24.13 ± 19.13 | 35.00 ± 20.43 | <0.001 | |
5.00 (2.75, 20.00) | 20.00 (12.75, 31.75) | 34.00 (22.75, 42.25) | |||
Dataset 2 | |||||
Cyano-PiB Load | 1.47 ± 2.12 | 1.16 ± 1.00 | 6.11 ± 5.73 | <0.001 | |
0.12 (0.00, 3.02) | 0.88 (0.23, 1.99) | 3.93 (1.89, 8.47) | |||
X-34 Load | 1.84 ± 2.47 | 2.24 ± 1.64 | 7.83 ± 7.21 | <0.001 | |
0.45 (0.00, 4.01) | 2.13 (1.74, 2.67) | 5.60 (1.96, 12.13) |
NCI, no cognitive impairment; MCI, mild cognitive impairment; AD, Alzheimer’s disease; mean ± standard deviation; median (interquartile range); *p-values that are <0.05 indicate the data do not meet the assumption of normality.